(Q27333275)

25 June 2017

Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype (English)

1 reference

25 June 2017

1 reference

15

1 reference

25 June 2017

14

John Q Trojanowski

1 reference

25 June 2017

13

Daniel Weintraub

1 reference

25 June 2017

8

John Roberts

1 reference

25 June 2017

7

James Leverenz

1 reference

25 June 2017

9

Ali Samii

1 reference

25 June 2017

6

Pinky Agarwal

1 reference

25 June 2017

Vivianna M Van Deerlin

5

object named as

Vivianna M Van Deerlin

1 reference

25 June 2017

11

Howard Hurtig

1 reference

25 June 2017

Christine R Swanson

1

1 reference

25 June 2017

Katherine Li

2

1 reference

25 June 2017

Travis L Unger

3

1 reference

25 June 2017

Michael D Gallagher

4

1 reference

25 June 2017

Rachel Goldmann Gross

10

1 reference

25 June 2017

Jacqueline Rick

12

1 reference

25 June 2017

Alice S Chen-Plotkin

16

1 reference

25 June 2017

language of work or name

English

0 references

publication date

16 September 2014

1 reference

25 June 2017

1 reference

25 June 2017

30

1 reference

25 June 2017

6

1 reference

25 June 2017

805-812

1 reference

An integrated map of genetic variation from 1,092 human genomes

25 June 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

An integrated encyclopedia of DNA elements in the human genome

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Does vigorous exercise have a neuroprotective effect in Parkinson disease?

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Genome-wide association study reveals genetic risk underlying Parkinson's disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

APOA1 polymorphism influences risk for early-onset nonfamiliar AD

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Prospective study of statin use and risk of Parkinson disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

The role of drug transporters at the blood-brain barrier

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

A polymorphism (G-->A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

The intestine as a source of apolipoprotein A1

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362847

Discontinuation of statin therapy associates with Parkinson disease: a population-based study.

2 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.26022

Gene-diet interactions on plasma lipid levels in the Inuit population

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.26022

Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.26022

New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia

21 January 2018

1 reference

12 December 2020

Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study

1 reference

12 December 2020

G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations

1 reference

12 December 2020

Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia

1 reference

12 December 2020

Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I

1 reference

12 December 2020

Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol

1 reference

12 December 2020

Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: A meta-analysis

1 reference

12 December 2020

Genetic polymorphisms in the APOA1 gene and their relationship with serum HDL cholesterol levels

1 reference

12 December 2020

Identifiers

DOI

10.1002/MDS.26022

1 reference

25 June 2017

0 references

1 reference